Dr. Xiaona Wang is an Associate Professor at the Henan Key Laboratory of Childrens Genetics and Metabolic Diseases, Childrens Hospital affiliated with Zhengzhou University, China. She obtained her Ph.D. in Neurobiology from Shandong University and completed her postdoctoral training in Biochemistry and Molecular Biology at Indiana University–Purdue University, Indianapolis, USA. Her research focuses on the molecular and circuit mechanisms underlying autism spectrum disorder, epilepsy, and intellectual disability, emphasizing neurotransmission, receptor regulation, and neuroprotective drug mechanisms. Dr. Wang has authored numerous papers in leading journals such as Molecular Neurobiology, Molecular Autism, Frontiers in Cellular Neuroscience, and Neurochemical Research. She serves as Academic Editor for PLoS One, Youth Editor for Clinical and Experimental Pharmacology and Physiology, and Guest Editor for Frontiers in Psychiatry. Dr. Wang has received several provincial scientific achievement awards and holds multiple invention patents in neurogenetic diagnostics and therapeutics. Her work significantly advances the biochemical and molecular understanding of neurodevelopmental and neurological disorders.
Molecular and Circuit Mechanisms Underlying Autism Spectrum Disorder, Epilepsy, and Intellectual Disability, Emphasizing Neurotransmission, Receptor Regulation, and Neuroprotective Drug Mechanisms
